Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases.

Li H, Yang W, Chen PW, Alizadeh H, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5522-8. doi: 10.1167/iovs.09-3804. Epub 2009 Jun 24.

2.

Differential expression of chemokine receptors on uveal melanoma cells and their metastases.

Li H, Alizadeh H, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):636-43. doi: 10.1167/iovs.07-1035.

PMID:
18235009
3.

Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.

van den Bosch T, Koopmans AE, Vaarwater J, van den Berg M, de Klein A, Verdijk RM.

Invest Ophthalmol Vis Sci. 2013 Nov 8;54(12):7354-61. doi: 10.1167/iovs.13-12407.

PMID:
24052640
4.

Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis.

Dobner BC, Riechardt AI, Joussen AM, Englert S, Bechrakis NE.

Acta Ophthalmol. 2012 Dec;90(8):e638-44. doi: 10.1111/j.1755-3768.2012.02515.x. Epub 2012 Nov 20.

5.

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.

Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S.

PLoS One. 2012;7(1):e29989. doi: 10.1371/journal.pone.0029989. Epub 2012 Jan 13.

6.

"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".

Franco R, Botti G, Mascolo M, Loquercio G, Liguori G, Ilardi G, Losito S, La Mura A, Calemma R, Ierano C, Bryce J, D'Alterio C, Scala S.

Front Biosci (Elite Ed). 2010 Jan 1;2:13-21.

PMID:
20036848
7.

Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.

Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2293-301.

PMID:
8843913
8.

Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.

Ma D, Niederkorn JY.

Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1067-75.

PMID:
9620065
9.

Human melanoma metastases express functional CXCR4.

Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G.

Clin Cancer Res. 2006 Apr 15;12(8):2427-33.

10.

Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.

Niederkorn JY, Mellon J, Pidherney M, Mayhew E, Anand R.

Curr Eye Res. 1993 Apr;12(4):347-58.

PMID:
8319494
11.

The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.

Bi J, Li P, Li C, He J, Wang Y, Zhang H, Fan X, Jia R, Ge S.

Tumour Biol. 2016 Mar;37(3):4175-82. doi: 10.1007/s13277-015-4259-4. Epub 2015 Oct 22.

PMID:
26490988
12.

Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.

Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J.

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):802-6.

13.

Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.

Surriga O, Rajasekhar VK, Ambrosini G, Dogan Y, Huang R, Schwartz GK.

Mol Cancer Ther. 2013 Dec;12(12):2817-26. doi: 10.1158/1535-7163.MCT-13-0499. Epub 2013 Oct 18.

14.

Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.

Ma D, Luyten GP, Luider TM, Niederkorn JY.

Invest Ophthalmol Vis Sci. 1995 Feb;36(2):435-41.

PMID:
7843912
15.

Modeling the behavior of uveal melanoma in the liver.

Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, Barak V, Majumdar D, Pe'er J, Maniotis AJ.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2967-74.

16.

Epigenetic regulation of CXCR4 expression by the ocular microenvironment.

Li H, Niederkorn JY, Sadegh L, Mellon J, Chen PW.

Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):234-43. doi: 10.1167/iovs.12-10643.

17.

Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis.

Yang H, Grossniklaus HE.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):28-34. doi: 10.1167/iovs.09-4138. Epub 2009 Aug 6.

18.

Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.

Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS.

Ann Surg. 2006 Jul;244(1):113-20.

19.

The role of RASSF1A in uveal melanoma.

Dratviman-Storobinsky O, Cohen Y, Frenkel S, Merhavi-Shoham E, El SD, Binkovsky N, Pe'er J, Goldenberg-Cohen N.

Invest Ophthalmol Vis Sci. 2012 Oct 3;53(6):2611-9. doi: 10.1167/iovs.11-7730.

PMID:
22447862
20.

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.

van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA.

Int J Cancer. 2003 Sep 10;106(4):472-9. Erratum in: Int J Cancer. 2004 Oct 10;111(6):982.

Supplemental Content

Support Center